MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$25,205K
EPS
-$3.13
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
16,744
General and administrative
13,660
Total operating loss
30,404
Interest income
3,920
Realized gain on sale of marketable securities, net
119
Gain (loss) on change in fair value of derivative instruments
1,161
Total non-operating income
5,200
Loss before income tax
-25,204
Income tax provision
1
Net loss
-25,205
Basic EPS
-3.13
Diluted EPS
-3.13
Basic Average Shares
8,045,145
Diluted Average Shares
8,045,145
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$25,205K Interest income$3,920K Gain (loss) on changein fair value of...$1,161K Realized gain on sale ofmarketable securities, net$119K Loss before incometax-$25,204K Income tax provision$1K Total non-operatingincome$5,200K Total operating loss$30,404K Research and development$16,744K General andadministrative$13,660K

LB PHARMACEUTICALS INC (LBRX)

LB PHARMACEUTICALS INC (LBRX)